The levels of the 2‐hour glucose tolerance test and the insulinogenic index showed a trend toward differences between the 2 groups (160.5±34.2 mg/dL versus 140.2±38.1 mg/dL [ P =0.056] and 0.42±0.15 versus 0.67±0.13 [ P =0.070], respectively), but these results were not statistically significant.
The analysis of time to treatment modification due to toxicity showed a trend (HR = 0.58, 95%CI = 0.33–1.01, P = 0.056) for FGFR4 rs351855 under an additive genetic model ( Table 3 ).
These symptoms improved after the patient underwent laparoscopic cholecystectomy.[ 32 ] Moreover, the improvement in GERD after LSG with HHR showed a trend approaching to be statistically significant ( P = 0.056).
26.7%; χ 2 = 4.54, P = 0.033) and showed a trend towards higher alcohol misuse as well (43.7% vs. 30.4%; χ 2 = 3.64, P = 0.056).
Baseline IL-6 showed a trend toward higher levels in the ≥3-session group (305.5 pg/mL, IQR 53.2–1306.3) than in the 1-session (143.1 pg/mL) or 2-session (37.0 pg/mL) groups ( p = 0.056), while baseline CRP and comorbidities such as diabetes, hypertension, obesity, and COPD were similarly distributed (all p > 0.28).
In the VO condition, the auditory ROI showed a trend of increased synchronization with the AV ROI (A-AV: p = 0.056).
Hepatic G6pdx was elevated in Tfm mice compared to XY mice ( p < 0.001) and testosterone treatment showed a trend to reducing this expression in Tfm mice ( p = 0.056).
Also, no significant change (factor days) in session time was found, but the interaction between training days and groups showed a trend ( F (3.940,43.340) = 2.521; p = 0.056).
Subgroup analysis, which focused only on patients with a CHA 2 DS 2 -VASc score of 0 for males (n = 19) and 1 for females (n = 6), was performed and EAT thickness could further identify CV events in males with a CHA 2 DS 2 -VASc score of 0 (IDI 0.13, 95% CI 0.05–0.21, P = 0.002) and showed a trend in further identifying CV events in females with a CHA 2 DS 2 -VASc score of 1 (IDI 0.10, 95% CI -0.01–0.20, P = 0.056), when compared with a Cox model containing CHA 2 DS 2 -VASc score, LAVI, LVEF, and E/E′.
2 ): T1 > T2 ( p < 0.001); - Time ( F = 33.63; p < 0.001) had a significant effect on the change of HAM-A scores, while diagnosis showed a trend to present a significant effect ( F = 2.36; p = 0.056) ( Fig. 3 ): T0 < T2 and T1 > T2 (both p values <0.001); SKZ patients overall < PD patients ( p = 0.02).
SAE risk was not significantly elevated for Resmetirom (RR: 1.11, 95% CI: [0.77; 1.59], p = 0.58), but GRAs showed a trend toward higher SAE rates (RR: 2.38, 95% CI: [0.98; 5.82], p = 0.056).
However, the recessive model of FcγRIIIA-176 F/V showed a trend towards protection against SMA, albeit with marginal significance (OR, 0.43, 95% CI, 0.18–1.02, P = 0.056).
NID showed a trend toward improvement from 13.3% ± 8.0% to 18.9% ± 5.4% ( P = 0.056).
5d ), and post hoc pairwise comparisons showed a trend towards increased omissions in the baseline session at the highest dose used ( p = 0.056).
However, we did not observe a significant difference in CD31 + endothelial areas between the two groups; however, the Batimastat-treated group showed a trend in more preserved CD31 + endothelial areas ( p = 0.056) (Fig. 6 D).
The interaction effect showed a trend ( F (2,26) = 3.24, P = .056).
Regarding the animals with clinical signs of metritis, the serum BHB and NEFA concentrations were not significantly different from the concentrations found in cows with no clinical signs, although the serum NEFAs showed a trend to be higher in cows with metritis ( p = 0.056).
Although the overall IDO1 positive expression rate was low in platinum‐resistant samples, they showed a trend for being more likely to be IDO1 positive ( p = 0.056). 4.
Although pregabalin showed a trend toward improvement on the Mahoney Pain Scale (MPS), the difference was not statistically significant compared to the placebo ( P = 0.056).
Further, the Heidelberg Bleeding Classification showed a trend towards statistically significant differences between the thrombectomy and control groups across the different categories ( p = 0.056) (Table S5 ).
In the CCRT subgroup, high-dose cisplatin showed a trend toward improved OS (HR = 0.57, 95% CI: 0.32–1.02, p = 0.056), with moderate-to-high heterogeneity (I 2 = 65.1%, P for heterogeneity = 0.057).
Disyllable performance showed a trend (estimate=-9.3, p =0.056), but was not statistically significant.
However, our data suggest that the higher BMI itself and hirsutism were of major influence on stress in overweight/obese women, whereas in lean/normal weight PCOS patients testosterone as a marker of overall disease severity showed a trend ( p= 0.056; Table 3 ).
Additionally, women showed a trend towards subjectively incomplete recovery in this multivariable model ( p = 0.056).
Concerning the effect of bonding, between the “with bond” and “without bond” subgroups, although no statistically significant difference was found for any of the materials ( p > 0.05), Helioseal F Plus showed a trend toward reduced microleakage with bonding ( p = 0.056).